SCHEMBL13764485

SCHEMBL13764485

Cc1cc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2c(CCc3ccc(OCCO)cc3)coc2c1

nearest known ligand 0.58

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ SLC5A2 P31639 14/20 0.58
▸ SLC5A1 P13866 10/20 0.58
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13764484 0.90 SLC5A2 (0.70) SLC5A2SLC5A1NPC1RAB9A
SCHEMBL1729084 0.90 SLC5A2 (0.59) SLC5A2SLC5A1POLB
SCHEMBL13764481 0.87 SLC5A2 (0.56) SLC5A2SLC5A1POLB
SCHEMBL1727288 0.86 SLC5A2 (0.58) SLC5A2SLC5A1
SCHEMBL1728376 0.82 SLC5A2 (0.57) SLC5A2SLC5A1
SCHEMBL1727413 0.80 SLC5A2 (0.51) SLC5A2SLC5A1
SCHEMBL13764495 0.79 SLC5A2 (0.56) SLC5A2SLC5A1
SCHEMBL1728413 0.79 SLC5A2 (0.70) SLC5A2SLC5A1
SCHEMBL1728250 0.79 SLC5A2 (0.60) SLC5A2SLC5A1
SCHEMBL1728886 0.79 SLC5A2 (0.53) SLC5A2SLC5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7566699-B2 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-07-28 — — US disclosed
US-7566699-B2 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-07-28 — — US disclosed
Send feedback